Prediabetes: a High-risk State for Diabetes Development

Overview

Journal Lancet

Publisher Elsevier

Specialty General Medicine

Date 2012 Jun 12

PMID 22683128

Citations 1129

Authors

Adam G Tabak

Christian Herder

Wolfgang Rathmann

Eric J Brunner

Mika Kivimaki

Affiliations

Soon will be listed here.

Abstract

Prediabetes (intermediate hyperglycaemia) is a high-risk state for diabetes that is defined by glycaemic variables that are higher than normal, but lower than diabetes thresholds. 5-10% of people per year with prediabetes will progress to diabetes, with the same proportion converting back to normoglycaemia. Prevalence of prediabetes is increasing worldwide and experts have projected that more than 470 million people will have prediabetes by 2030. Prediabetes is associated with the simultaneous presence of insulin resistance and β-cell dysfunction-abnormalities that start before glucose changes are detectable. Observational evidence shows associations between prediabetes and early forms of nephropathy, chronic kidney disease, small fibre neuropathy, diabetic retinopathy, and increased risk of macrovascular disease. Multifactorial risk scores using non-invasive measures and blood-based metabolic traits, in addition to glycaemic values, could optimise estimation of diabetes risk. For prediabetic individuals, lifestyle modification is the cornerstone of diabetes prevention, with evidence of a 40-70% relative-risk reduction. Accumulating data also show potential benefits from pharmacotherapy.

Citing Articles

Association between percent body fat and the risk of prediabetes among Chinese adults: a 5-years longitudinal cohort study.

Li X, Yu H, Yu K, Huang Z, Deng Z Sci Rep. 2025; 15(1):8982.

PMID: 40089546 DOI: 10.1038/s41598-025-92367-0.

Changes in expression of inflammatory cytokines and ocular indicators in pre-diabetic patients with cataract.

Chen Y, Meng Y, Tan M, Ma J, Zhu J, Ji M BMC Ophthalmol. 2025; 25(1):119.

PMID: 40065310 PMC: 11892156. DOI: 10.1186/s12886-025-03892-5.

Study on the pharmacodynamics and related mechanism of Tangningtongluo tablet on prediabetes mice based on the theory of "liver controlling dispersion".

Hu X, Gui L, Qi M, Zhu W, Ren Y, Li J J Tradit Complement Med. 2025; 15(2):182-191.

PMID: 40060155 PMC: 11883641. DOI: 10.1016/j.jtcme.2024.06.011.

Healthcare workers' perspectives on barriers and facilitators to referral to type 2 diabetes prevention programmes: a systematic review.

Haseldine C, Pallin J, Kearney P, Mc Hugh S, Riordan F, Cotterill S BMJ Open. 2025; 15(3):e090105.

PMID: 40054870 PMC: 11891527. DOI: 10.1136/bmjopen-2024-090105.

Effects of Endurance Training and Chlorogenic Acid on Oxidative and Nitrosative Stress Markers in Prediabetic Male Mice.

Ghasemi Pour S, Marandi S Int J Prev Med. 2025; 16:5.

PMID: 40046694 PMC: 11878644. DOI: 10.4103/ijpvm.ijpvm_122_23.

References

Sattar N, McConnachie A, Ford I, Gaw A, Cleland S, Forouhi N . Serial metabolic measurements and conversion to type 2 diabetes in the west of Scotland coronary prevention study: specific elevations in alanine aminotransferase and triglycerides suggest hepatic fat accumulation as a potential contributing factor. Diabetes. 2007; 56(4):984-91. DOI: 10.2337/db06-1256. View

. Age- and sex-specific prevalences of diabetes and impaired glucose regulation in 13 European cohorts. Diabetes Care. 2002; 26(1):61-9. DOI: 10.2337/diacare.26.1.61. View

Butler A, Janson J, Bonner-Weir S, Ritzel R, Rizza R, Butler P . Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes. 2002; 52(1):102-10. DOI: 10.2337/diabetes.52.1.102. View

Wan Q, Wang F, Guan Q, Liu Y, Wang C, Feng L . Regression to normoglycaemia by fenofibrate in pre-diabetic subjects complicated with hypertriglyceridaemia: a prospective randomized controlled trial. Diabet Med. 2010; 27(11):1312-7. DOI: 10.1111/j.1464-5491.2010.03107.x. View

Wilson P, Meigs J, Sullivan L, Fox C, Nathan D, DAgostino Sr R . Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study. Arch Intern Med. 2007; 167(10):1068-74. DOI: 10.1001/archinte.167.10.1068. View

Feig D, Zinman B, Wang X, Hux J . Risk of development of diabetes mellitus after diagnosis of gestational diabetes. CMAJ. 2008; 179(3):229-34. PMC: 2474881. DOI: 10.1503/cmaj.080012. View

Chiasson J, Josse R, Gomis R, Hanefeld M, Karasik A, Laakso M . Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial. JAMA. 2003; 290(4):486-94. DOI: 10.1001/jama.290.4.486. View

Grover S, Lowensteyn I, Kaouache M, Marchand S, Coupal L, DeCarolis E . The prevalence of erectile dysfunction in the primary care setting: importance of risk factors for diabetes and vascular disease. Arch Intern Med. 2006; 166(2):213-9. DOI: 10.1001/archinte.166.2.213. View

Salpeter S, Buckley N, Kahn J, Salpeter E . Meta-analysis: metformin treatment in persons at risk for diabetes mellitus. Am J Med. 2008; 121(2):149-157.e2. DOI: 10.1016/j.amjmed.2007.09.016. View

10.

Danaei G, Finucane M, Lu Y, Singh G, Cowan M, Paciorek C . National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants. Lancet. 2011; 378(9785):31-40. DOI: 10.1016/S0140-6736(11)60679-X. View

11.

Bosch J, Yusuf S, Gerstein H, Pogue J, Sheridan P, Dagenais G . Effect of ramipril on the incidence of diabetes. N Engl J Med. 2006; 355(15):1551-62. DOI: 10.1056/NEJMoa065061. View

12.

Grandinetti A, Chow D, Sletten D, Oyama J, Theriault A, Schatz I . Impaired glucose tolerance is associated with postganglionic sudomotor impairment. Clin Auton Res. 2007; 17(4):231-3. DOI: 10.1007/s10286-007-0426-z. View

13.

Gong Q, Gregg E, Wang J, An Y, Zhang P, Yang W . Long-term effects of a randomised trial of a 6-year lifestyle intervention in impaired glucose tolerance on diabetes-related microvascular complications: the China Da Qing Diabetes Prevention Outcome Study. Diabetologia. 2010; 54(2):300-7. DOI: 10.1007/s00125-010-1948-9. View

14.

Seshasai S, Kaptoge S, Thompson A, Di Angelantonio E, Gao P, Sarwar N . Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med. 2011; 364(9):829-841. PMC: 4109980. DOI: 10.1056/NEJMoa1008862. View

15.

Schroeder E, Chambless L, Liao D, Prineas R, Evans G, Rosamond W . Diabetes, glucose, insulin, and heart rate variability: the Atherosclerosis Risk in Communities (ARIC) study. Diabetes Care. 2005; 28(3):668-74. DOI: 10.2337/diacare.28.3.668. View

16.

Nathan D, Buse J, Davidson M, Ferrannini E, Holman R, Sherwin R . Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia. 2008; 52(1):17-30. DOI: 10.1007/s00125-008-1157-y. View

17.

Hamman R, Wing R, Edelstein S, Lachin J, Bray G, Delahanty L . Effect of weight loss with lifestyle intervention on risk of diabetes. Diabetes Care. 2006; 29(9):2102-7. PMC: 1762038. DOI: 10.2337/dc06-0560. View

18.

. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care. 2009; 32(7):1327-34. PMC: 2699715. DOI: 10.2337/dc09-9033. View

19.

Rathmann W, Kowall B, Heier M, Herder C, Holle R, Thorand B . Prediction models for incident type 2 diabetes mellitus in the older population: KORA S4/F4 cohort study. Diabet Med. 2010; 27(10):1116-23. DOI: 10.1111/j.1464-5491.2010.03065.x. View

20.

Bruce S, Young T . Prevalence and risk factors for neuropathy in a Canadian First Nation community. Diabetes Care. 2008; 31(9):1837-41. PMC: 2518355. DOI: 10.2337/dc08-0278. View